Risk of Fractures with Glitazones: A Critical Review of the Evidence to Date

ISSN： 0114-5916

Source： Drug Safety, Vol.32, Iss.7, 2009-07, pp. : 539-547

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benzodiazepines and Risk of Hip Fractures in Older People: A Review of the Evidence

By Cumming R.G. Couteur D.G.L.

CNS Drugs, Vol. 17, Iss. 11, 2003-01 ,pp. : 825-837

Adis International

Access to resources Recommend Favorite

Vision Disorders and Phosphodiesterase Type 5 Inhibitors: A Review of the Evidence to Date

By Laties Alan M.

Drug Safety, Vol. 32, Iss. 1, 2009-01 ,pp. : 1-18

Adis International

Access to resources Recommend Favorite

Aristolochic Acid and Chinese Herbs Nephropathy: A Review of the Evidence to Date

By Cosyns J-P.

Drug Safety, Vol. 26, Iss. 1, 2003-01 ,pp. : 33-48

Adis International

Access to resources Recommend Favorite

Inhaled Corticosteroids and the Risk of Fractures in Older Adults: A Systematic Review and Meta-Analysis

By Etminan Mahyar

Drug Safety, Vol. 31, Iss. 5, 2008-01 ,pp. : 409-414

Adis International

Access to resources Recommend Favorite

Psychoeducation in Subjects at Elevated Risk for Psychosis - A Critical Review

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-02 ,pp. : 566-569

Bentham Science Publishers

Access to resources Recommend Favorite